M. Yair Levy, M.D. serves as the director of hematologic malignancies research and specializes in hematology, including lymphoma, myeloma, and leukemia. With many new FDA approvals in hematology therapies, Dr. Levy is proud to have offered clinical trials for his patients before their FDA approvals.